Article Information
History
- April 16, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Eduard Grebe1,2,3,#,
- Elaine A. Yu1,
- Marjorie D. Bravo4,
- Alex Welte3,
- Roberta L. Bruhn1,2,
- Mars Stone1,2,
- Valerie Green5,
- Phillip C. Williamson5,
- Leora R. Feldstein6,
- Jefferson M. Jones6,
- Michael P. Busch1,2,* and
- Brian Custer1,2,*
- 1Vitalant Research Institute, San Francisco, CA
- 2University of California San Francisco, San Francisco, CA
- 3SACEMA, Stellenbosch University, Stellenbosch, South Africa
- 4Corporate Medical Affairs, Vitalant, Scottsdale, AZ
- 5Creative Testing Solutions, Tempe, AZ
- 6Centers for Disease Control and Prevention, Atlanta, GA
- ↵#Corresponding author; email: egrebe{at}vitalant.org
Posted April 16, 2022.
COVID-19 vaccine effectiveness against SARS-CoV-2 infection in the United States prior to the Delta and Omicron-associated surges: a retrospective cohort study of repeat blood donors
